Controlling the Glycosylation Profile in mAbs Using Time-Dependent Media Supplementation

In order to meet desired drug product quality targets, the glycosylation profile of biotherapeutics such as monoclonal antibodies (mAbs) must be maintained consistently during manufacturing. Achieving consistent glycan distribution profiles requires identifying factors that influence glycosylation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Radhakrishnan, Devesh, Robinson, Anne S., Ogunnaike, Babatunde A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698858/
https://www.ncbi.nlm.nih.gov/pubmed/31544854
http://dx.doi.org/10.3390/antib7010001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698858/
https://www.ncbi.nlm.nih.gov/pubmed/31544854
http://dx.doi.org/10.3390/antib7010001

Ejemplares similares